✦ LIBER ✦
42 POSTER NPI-2358 (a novel vascular disrupting agent) Phase 1 dose escalation trial with an RP2D cohort
✍ Scribed by M. Mita; M.A. Spear; L.K. Yee; K.P. Papadopoulos; E.I. Heath; M. Pilat; O. Romero; G.K. Lloyd; A. Mita; P. LoRusso
- Book ID
- 119599197
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 65 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.